Mediland Pharm Limited reported unaudited consolidated earnings results for the half year ended December 31, 2019. For the period, the company reported revenue of AUD 19,393,774 compared to AUD 13,358,134 a year ago. Loss after income tax for the half year attributable to members of the company was AUD 795,249 compared to profit of AUD 378,411 a year ago. Basic loss per share were 0.25 cents compared to earnings of 0.52 cents a year ago.